In vitro antimicrobial activity of douro wines against  clinical Helicobacter Pylori Strains

Lidia Po Catalao Dionisio; Alejandro Manuel Labella; María  Palma; Juan José  Borrego

doi:10.22490/24629448.5499

Vol. 19 No. 37 (2021)

Published

2021-12-23

PDF (Spanish)

How to Cite

Catalao Dionisio , L. P., Labella , A. M., Palma , M. ., & Borrego , J. J. . (2021). In vitro antimicrobial activity of douro wines against clinical Helicobacter Pylori Strains. NOVA Biomedical Sciences Journal, 19(37), 121-134. https://doi.org/10.22490/24629448.5499

Download Citation

Metrics

Metrics Loading ...

In vitro antimicrobial activity of douro wines against clinical Helicobacter Pylori Strains

DOI: https://doi.org/10.22490/24629448.5499

Section

Investigación original

Lidia Po Catalao Dionisio

Alejandro Manuel Labella Universitario Teatinos

María Palma Universidade do Algarve

Juan José Borrego

Aim. In vitro antimicrobial activities of seven wines (5 reds and 2 whites) from the Douro region (Iberian Peninsule) against eleven clinical strains of Helicobacter pylori were evaluated.

Methods. The disk diffusion method, using Columbia Agar supplemented with horse blood (CAB), were used to determine the antimicrobial properties of some wine components against H. pylori strains. Potential interactions of antioxidants contained in the wines and two antimicrobials (amoxicillin and metronidazole) were studied by the disk diffusion method.

Results. All the tested strains showed growth in CAB supplemented with 9% of the tested wines but none of them grew in media supplemented with 45% and 67.5% of wine. Similarly, all the tested strains grew in media with the concentration of proanthocyanidins present in the different types of the studied wines. The Minimal Inhibitory Concentration (MIC) values of the wine antioxidant components tested (benzoic acid, catechin, quercetin, and resveratrol) indicate that resveratrol was the most powerful inhibitory substance against H. pylori. An effect of potentiation between amoxicillin and metronidazole and the antioxidants tested was also established. The interaction of amoxicillin and resveratrol or metronidazole and catechin increased the antimicrobial activity against H. pylori.

Conclusions. The results obtained suggested a potential role of resveratrol as a chemopreventive agent for H. pylori infection.

Helicobacter pylori, antioxidants, antimicrobial activity, Duero wine, resveratrol, proanthocyanidins

Kusters JG, van Vliet AHM, Kuipers E. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev. 2006; 19:449-490. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1539101/pdf/0054-05.pdf

Du MQ, Isaccson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol. 2002; 3:97-104. https://www.sciencedirect.com/science/article/pii/S1470204502006514?via%3Dihub

Sachs G, Weeks DL, Melchers K, Scott DR. The gastric biology of Helicobacter pylori. Annu Rev Physiol. 2003; 65:349-369. https://www.annualreviews.org/doi/pdf/10.1146/annurev.physiol.65.092101.142156

Dundon WG, de Bernard M, Montecucco C. Virulence factors of Helicobacter pylori. Int J Med Microbiol. 2001; 290:647-658. doi: 10.1016/s1438-4221(01)80002-3.

Laheij RJ, Rossum LG, Jansen JB, Straatman H, Verbeek AL. Evaluation of treatment regimens to cure Helicobacter pylori infection: a meta-analysis. Aliment Pharmacol Ther. 1999; 13:857-864. https://onlinelibrary.wiley.com/doi/epdf/10.1046/j.1365-2036.1999.00542.x

Malfertheiner P, Mégraud F, O'Morain C, Hungin APS, Jones R, Axon A, et al. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther. 2002; 16:167-180. https://onlinelibrary.wiley.com/doi/epdf/10.1046/j.1365-2036.2002.01169.x

Debets-Ossenkopp YJ, Namavar F, MacLaren DM. Effect of an acidic environment on the susceptibility of Helicobacter pylori to trospectomycin and other antimicrobial agents. Eur J Clin Microbiol Infect Dis. 1995; 14:353-355. doi: 10.1007/BF02116532.

Gerrits MM, van Vliet AHM, Kuipers E, Kusters JG. Helicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications. The Lancet Infect Dis. 2006; 6:699-709. https://www.sciencedirect.com/science/article/pii/S1473309906706272?via%3Dihub

Macias-Garcia F, Llovo-Taboada J, Diaz-Lopez M, Baston-Rey I, Dominguez-Munoz JE. High primary antibiotic resistance of Helicobacter pylori strains isolated from dyspeptic patients: a prevalence cross-sectional study in Spain. Helicobacter. 2017;22: e12440. https://onlinelibrary.wiley.com/doi/epdf/10.1111/hel.12440

Alba C, Blanco A, Alarcon T. Antibiotic resistance in Helicobacter pylori. Curr Opin Infect Dis. 2017;30: 489-497. https://journals.lww.com/co-infectiousdiseases/Fulltext/2017/10000/Antibiotic_resistance_in_Helicobacter_pylori.8.aspx

Walduck AK, Raghavan S. Immunity and vaccine development against Helicobacter pylori. In: Kamiya S, Backert S, eds. Helicobacter pylori in Human Diseases. Advances in Experimental Medicine and Biology, vol 1149, Cham.: Springer; 2019. p. 257-275. https://link.springer.com/chapter/10.1007%2F5584_2019_370

Collado MC, Gonzalez A, Gonzalez R, Hernandez M, Ferrus MA, Sanz Y. Antimicrobial peptides are among the antagonistic metabolites produced by bifidobacterium against Helicobacter pylori. Int J Antimicrob Agents. 2005; 25:385-391. https://www.sciencedirect.com/science/article/pii/S0924857905000312?via%3Dihub

Stojilijkovic I, Evavold BD. (2001) Antimicrobial properties of porphyrins. Expert Opin Investig Drugs. 2001; 10:309-320. https://www.tandfonline.com/doi/abs/10.1517/13543784.10.2.309

Ohno T, Kita M, Yamaoka Y, Imamura S, Yamamoto T, Mitsufuji S, et al. Antimicrobial activity of essential oils against Helicobacter pylori. Helicobacter. 2003; 8:207-215. https://onlinelibrary.wiley.com/doi/full/10.1046/j.1523-5378.2003.00146.x?sid=nlm%3Apubmed

Tombola F, Campello S, De Luca L, Ruggiero P, Del Giudice G, Papini E, et al. Plant polyphenols inhibit VacA, a toxin secreted by the gastric pathogen Helicobacter pylori. FEBS Lett. 2003; 543:184-189. https://febs.onlinelibrary.wiley.com/doi/full/10.1016/S0014-5793%2803%2900443-5?sid=nlm%3Apubmed

Eurogast Study Group. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. Gut. 1993; 34:1672- 1676. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1374460/

Brenner H, Rothenbacher D, Bode G, Adler G. Relation of smoking and alcohol and coffee consumption to active Helicobacter pylori infection: Cross sectional study. Br Med J. 1997; 315:1489-1492. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127930/

Bujanda L. The effects of alcohol consumption upon the gastrointestinal tract. Am J Gastroenterol. 2000; 95:3374-3382. https://insights.ovid.com/pubmed?pmid=11151864

Brenner H, Bode G, Adler G, Hoffmeister A, Koenig W, Rothenbacher D. Alcohol as a gastric disinfectant? The complex relationship between alcohol consumption and current Helicobacter pylori infection. Epidemiology. 2001; 12:209-214. https://journals.lww.com/epidem/Fulltext/2001/03000/Alcohol_as_a_Gastric_Disinfectant__The_Complex.13.aspx

Murray LJ, Lane AJ, Harvey IM, Donovan JL, Nair P, Harvey RF. Inverse relationship between alcohol consumption and active Helicobacter pylori infection: The Bristol Helicobacter Project. Am J Gastroenterol. 2002; 97:2750-2755. https://insights.ovid.com/pubmed?pmid=12425543

Marimon JM, Bujanda L, Gutierrez-Stampa MA, Cosme A, Arenas JI. In vitro bactericidal effect of wine against Helicobacter pylori. Am J Gastroenterol. 1998; 93:1392. https://insights.ovid.com/pubmed?pmid=9707086

Glupczynski Y. Culture of Helicobacter pylori from biopsies and antimicrobial susceptibility testing. In: Megraud F, Lee A, eds. Helicobacter pylori: Techniques for Clinical Diagnosis and Basic Research, Oxford: WB Saunders Company, p. 17-32. 1996.

Megraud F, Lee A. Helicobacter pylori: Techniques for Clinical Diagnostics and Basic Research. Oxford: WB Saunders Company; 1996.

CLSI/NCCLS. Performance Standards for Antimicrobial Susceptibility Testing. Approved Standard M100-S19. Wayne: CLSI; 2009.

National Committee for Clinical Laboratory Standards (NCCLS). Development of in vitro Susceptibility Testing Criteria and Quality Control Parameters, 5th Ed. Philadelphia: American Society for Testing of Materials; 2018.

Oleastro M, Gerhard M, Lopes AI, Ramalho P, Cabral J, Guerreiro AS, et al. Helicobacter pylori virulence genotypes in Portuguese children and adults with gastroduodenal pathology. Eur J Clin Microbiol Infect Dis. 2003; 22:85-91. https://link.springer.com/article/10.1007/s10096-002-0865-3

Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high-molecular- mass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect Immun. 1993; 61:1799-1809. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC280768/

Atherton JC, Cao P, Peek RM. Mosaicism in the vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995; 270:17771-17779. https://www.sciencedirect.com/science/article/pii/S0021925817480100?via%3Dihub

Roggero JP, Coen S, Archier P, Rocheville-Divorne C. Etude par C.L.H.P. de la reaction glucoside de malvidine-acetaldehyde-compose phenolique. Conn Vigne Vin. 1987; 21:163-168. https://oeno-one.eu/article/view/1283

Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007; 20:280-322. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865594/

Ecclissato C, Marchioretto MAM, Mendonça S, Godoy APO, Guersoni RA, Deguer M, et al. Increased primary resistance to recommended antibiotics negatively affects Helicobacter pylori eradication. Helicobacter. 2002; 7:53-59. https://onlinelibrary.wiley.com/doi/full/10.1046/j.1523-5378.2002.00056.x?sid=nlm%3Apubmed

Lee SY, Shin YW, Hahm KB. Phytoceuticals: mighty but ignored weapons against Helicobacter pylori infection. J Dig Dis. 2008; 9:129-139. https://onlinelibrary.wiley.com/doi/full/10.1111/j.1751-2980.2008.00334.x

Daroch F, Hoeneisen M, Gonzalez CL, Kawaguchi F, Salgado F, Solar H, et al. In vitro antibacterial activity of Chilean red wines against Helicobacter pylori. Microbios. 2001; 104:79-85. https://pubmed.ncbi.nlm.nih.gov/11297014/

Just JR, Daeschel MA. Antimicrobial effects of wine on Escherichia coli O157:H7 and Salmonella typhimurium in a model stomach system. J Food Sci. 2003; 68:285- 290. https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1365-2621.2003.tb14154.x

Møretrø T, Daeschel MA. Wine is bactericidal to foodborne pathogens. J Food Sci. 2004; 69:M251-257. https://onlinelibrary.wiley.com/doi/epdf/10.1111/j.1365-2621.2004.tb09938.x

Friedman M. Antibacterial, antiviral, and antifungal properties of wines and winery byproducts in relation to their ﬂavonoid content. J Agric Food Chem. 2014; 62:6025- 6042. https://pubs.acs.org/doi/10.1021/jf501266s

Kamei H, Hashimoto Y, Koide T, Kojima T, Hasegawa S. Anti-tumor of methanol extracts from red and white wines. Cancer Biother Radiopharm. 1998; 13:447-452. https://www.liebertpub.com/doi/10.1089/cbr.1998.13.447?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub++0pubmed&

Belleville J. The French paradox: possible involvement of ethanol in the protective effect against cardiovascular diseases. Nutrition. 2002; 18:173-177.

Daglia, M. Polyphenols as antimicrobial agents. Curr Opin Biotechnol. 2012; 23:174- 181. https://www.sciencedirect.com/science/article/pii/S0899900701007213?via%3Dihub

Mahady GB, Pendland SL. Resveratrol inhibits the growth of Helicobacter pylori in vitro. Am J Gastroenterol. 2000; 95:1849. https://insights.ovid.com/pubmed?pmid=10926010

Wang D, Xu Y, Liu W. Tissue distribution and excretion of resveratrol in rat alter oral administration of Polygonum cuspidatum extract (PCE). Phytomedicine. 2008; 15:859-866. https://www.sciencedirect.com/science/article/pii/S0944711308000287?via%3Dihub

Orallo F. Trans-resveratrol: a magical elixir of eternal youth?. Curr Med Chem. 2008; 15:1887-1898. https://pubmed.ncbi.nlm.nih.gov/18691046/

Mahady GB, Pendland SL, Chadwick LR. Resveratrol and red wine extracts inhibit the growth of CagA + strains of Helicobacter pylori in vitro. Am J Gastroenterol. 2003; 98:1440-1441. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860858/

Dong W, Zhon Y, Yang Z. Research progress of mechanism of action of resveratrol. Pharmacol Pharm. 2016; 7:170-175. DOI: 10.4236/pp.2016.74022

Ghiara P, Marchetti M, Blaser MJ, Tummuru MK, Cover TL, Segal ED, et al. Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun. 1995; 63:4154-4160. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC173584/

Salama NR, Otto G, Tompkins L, Falkow S. Vacuolating cytotoxin of Helicobacter pylori plays a role during colonization in a mouse model of infection. Infect Immun. 2001; 69:730-736. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC97945/

Hemaiswarya S, Kruthiventi AK, Doble M. Synergism between natural products and antibiotics against infectious disease. Phytomedicine. 2008; 15:639-652. https://www.sciencedirect.com/science/article/pii/S0944711308001104?via%3Dihub

Sung WG, Lee DG. Mechanism of decreased susceptibility for Gram-negative bacteria and synergistic effect with ampicillin of indole-3-carbinol. Biol Pharm Bull. 2008; 31:1798-1801. https://pubmed.ncbi.nlm.nih.gov/18758080/

Download Citation

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Published

How to Cite

In vitro antimicrobial activity of douro wines against clinical Helicobacter Pylori Strains

Declaración de privacidad.

Keywords